CEROW
CERO THERAPEUTICS HOLDINGS, INC.
NASDAQ · Healthcare · Biotechnology · US
$0.00
+63.55%Latest reported
- Last report date
- May 15, 2026
- EPS actual
- -$0.20
- EPS estimate
- -$0.80
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +88.0%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| May 15, 2026 | -$0.80 | -$0.20 | Beat 75.01% | — |
| Nov 19, 2025 | — | -$9.10 | — | — |
| Aug 22, 2025 | -$124 | -$11 | Beat 91.07% | — |
| May 15, 2025 | -$76 | -$1.49 | Beat 98.03% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of May 15, 2026